$6.23
+0.25 (+4.18%)
Open$5.95
Previous Close$5.98
Day High$6.36
Day Low$5.37
52W High$15.74
52W Low$1.55
Volume—
Avg Volume51.9K
Market Cap23.99M
P/E Ratio—
EPS$-10.27
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+465.8% upside
Current
$6.23
$6.23
Target
$35.25
$35.25
$27.20
$35.25 avg
$53.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.98M | 7.00M | 7.72M |
| Net Income | -1,326,181 | -1,545,557 | -1,571,652 |
| Profit Margin | -19.0% | -22.1% | -20.4% |
| EBITDA | -1,878,590 | -1,945,549 | -2,406,257 |
| Free Cash Flow | -1,092,947 | -1,597,568 | -1,077,092 |
| Rev Growth | +10.9% | +1.3% | +2.5% |
| Debt/Equity | 0.21 | 0.18 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |